Delivery Order SPE2DX15D9114-BD03

Award Date 8/25/17
Potential Completion Date 9/14/17
Potential Value $92K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $6,848.92 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for use by the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract is a $46,732.08 firm fixed-price delivery order placed under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. Through this...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $30,691.70 firm fixed-price delivery order from the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract provides a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides the Defense Logistics Agency (DLA) with a wide range of pharmaceutical products and medical supplies. The contract, valued at up to $57,317.20, is a firm fixed-price delivery order with no set-aside designation. The contract covers a comprehensive array of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables. The award, valued at $4,321.50, is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC, valid...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. The contract, valued at up to $24,341.81, is a firm fixed-price delivery order under the DLA's larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $3,091.04. It was issued by the Defense Logistics Agency (DLA), which supports the medical supply needs of the Department of Defense (DoD). The contract covers the delivery of a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) valued at $499,999,999 and valid through November 2026. The delivery order, valued at $89,953.38, is for the provision of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of pharmaceutical products and medical supplies. The $17,795.10 contract has a period of performance through March 14, 2024. This order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract valued up to $4,999,999 that DMS Pharmaceutical Group holds with the DLA...
  • SPE2DX15D9114
    Indefinite Delivery Contract
  • SPE2DX15D9114-BD03
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products and medical supplies to support the medical needs of the Department of Defense (DoD) healthcare facilities. The contract, valued at $92,102.40, is a firm fixed-price delivery order awarded under the DLA's SPE2DB Indefinite Delivery Contract (IDC) program, which has a total potential value of $499,999,999 and is valid through November 2026. DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the DLA and other federal agencies. This contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 4/3/25, 2:14 AM